Patient demographic and clinical characteristics
| PPI users (n=199) | PPI non-users (n=282) | p Value | ||
|---|---|---|---|---|
| Age | Year, mean±SD (range) | 67.5±11.7 (31–91) | 62.8±14.6 (20–87) | <0.01* |
| Sex | Male/female | 108 (54.2%)/91 (45.8%) | 151 (53.5%)/131 (46.5%) | NS† |
| Cirrhosis | Present/absent | 55 (27.6%)/144 (72.4%) | 57 (20.2%)/225 (79.8%) | 0.06† |
| Diabetes | Present/absent | 26 (13.1%)/173 (86.9%) | 34 (12.1%)/248 (87.9%) | NS† |
| Hypertension | Present/absent | 60 (30.2%)/139 (69.8%) | 57 (20.2%)/225 (79.8%) | <0.01† |
| Dyslipidaemia | Present/absent | 35 (17.6%)/164 (82.4%) | 22 (7.8%)/260 (92.2%) | <0.01† |
| Serum Cr | mg/dL, mean±SD (range) | 0.79±0.30 (0.35–3.68) | 0.73±0.26 (0.26–2.73) | <0.01* |
| Serum Mg | mg/dL, mean±SD (range) | 1.86±0.21 (1.2–2.5) | 1.91±0.19 (1.1–2.5) | <0.01* |
| Serum Alb | g/dL, mean±SD (range) | 4.06±0.54 (2.5–5.1) | 4.08±0.53 (2.4–5.2) | NS* |
*Calculated using the t test.
†Calculated using the χ2 test.
PPI, proton pump inhibitor; NS, no significance.